Search Results - "Gnjatic, S."
-
1
CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens
Published in Nucleic acids research (01-01-2009)“…The potency of the immune response has still to be harnessed effectively to combat human cancers. However, the discovery of T-cell targets in melanomas and…”
Get full text
Journal Article -
2
Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope
Published in Oncoimmunology (02-10-2016)“…Long synthetic peptides and CpG-containing oligodeoxynucleotides are promising components for cancer vaccines. In this phase I trial, 19 patients received a…”
Get full text
Journal Article -
3
Immune response, safety, and overall survival of NY-ESO-1+ soft tissue sarcoma patients treated with CMB305 therapy
Published in Annals of oncology (01-10-2018)Get full text
Journal Article -
4
NY-ESO-1 is associated with an aggressive phenotype of ovarian cancer
Published in Gynecologic oncology (01-06-2017)Get full text
Journal Article -
5
Improving the efficacy of cancer immunotherapy
Published in European Journal of Cancer (01-05-2009)“…Abstract A series of cancer vaccines have been evaluated in clinical trials with encouraging results, but the demonstration of clinical benefit in confirmatory…”
Get full text
Journal Article -
6
Recombinant MAGE-A3 protein immunotherapy and peripheral blood lymphocyte (PBL) reconstitution induce strong antigen-specific humoral and cellular immune responses in patients undergoing autologous stem cell transplantation (ASCT) for consolidation of multiple myeloma (MM)
Published in Clinical lymphoma, myeloma and leukemia (01-09-2015)Get full text
Journal Article -
7
Cancer-testis antigen expression and immunogenicity in AL amyloidosis
Published in Blood cancer journal (New York) (01-09-2012)“…Light-chain amyloidosis (AL) is a plasma cell dyscrasia closely related to multiple myeloma. In multiple myeloma, the cancer-testis antigens (CTAs) CT7…”
Get full text
Journal Article -
8
Single-cell immune landscape of human atherosclerotic plaques
Published in Nature medicine (01-10-2019)“…Atherosclerosis is driven by multifaceted contributions of the immune system within the circulation and at vascular focal sites. However, specific…”
Get full text
Journal Article -
9
Classification of current anticancer immunotherapies
Published in Oncotarget (30-12-2014)“…© 2014. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,…”
Get full text
Journal Article -
10
-
11
Cancer classification using the Immunoscore: a worldwide task force
Published in Journal of translational medicine (03-10-2012)“…Prediction of clinical outcome in cancer is usually achieved by histopathological evaluation of tissue samples obtained during surgical resection of the…”
Get full text
Journal Article -
12
Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative
Published in PLoS genetics (03-11-2022)“…Host genetics is a key determinant of COVID-19 outcomes. Previously, the COVID-19 Host Genetics Initiative genome-wide association study used common variants…”
Get full text
Journal Article -
13
Myeloid Cell-associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing
Published in Clinical cancer research (01-08-2021)“…To define dominant molecular and cellular features associated with PD-1/PD-L1 blockade resistance in metastatic urothelial cancer. We pursued an unbiased…”
Get full text
Journal Article -
14
Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis
Published in Gastroenterology (New York, N.Y. 1943) (01-04-2023)“…Better biomarkers for prediction of ulcerative colitis (UC) development and prognostication are needed. Anti-integrin αvβ6 (anti-αvβ6) autoantibodies have been…”
Get full text
Journal Article -
15
Intraepithelial CD8+ Tumor-Infiltrating Lymphocytes and a High $CD8^+/regulatory$ T Cell Ratio Are Associated with Favorable Prognosis in Ovarian Cancer
Published in Proceedings of the National Academy of Sciences - PNAS (20-12-2005)“…In a recent report, [Zhang et al. (2003) N. Engl. J. Med. 348,203-213], the presence of CD3+ tumor-infiltrating lymphocytes (TILs) was found to correlate with…”
Get full text
Journal Article -
16
A196 CSF2 AUTOANTIBODIES AS A SEROLOGICAL MARKER FOR CROHN'S DISEASE
Published in Journal of the Canadian Association of Gastroenterology (14-02-2024)“…Abstract Background Crohn’s disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract that severely affects quality of life. Despite…”
Get full text
Journal Article -
17
Phase I Clinical Trial of Mixed Bacterial Vaccine (Coley's Toxins) in Patients with NY-ESO-1 Expressing Cancers: Immunological Effects and Clinical Activity
Published in Clinical cancer research (01-10-2012)“…Mixed bacterial vaccine (MBV, Coley's toxins) is a historical, vaguely defined preparation of heat-inactivated Streptococcus pyogenes and Serratia marcescens…”
Get full text
Journal Article -
18
Spatial analyses of immune cell infiltration in cancer: current methods and future directions. A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer
Published in The Journal of pathology (01-08-2023)“…Modern histologic imaging platforms coupled with machine learning methods have provided new opportunities to map the spatial distribution of immune cells in…”
Get full text
Journal Article -
19
Image‐based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno‐oncology Biomarker Working Group on Breast Cancer
Published in The Journal of pathology (01-03-2024)“…Recent advances in the field of immuno‐oncology have brought transformative changes in the management of cancer patients. The immune profile of tumours has…”
Get full text
Journal Article -
20
Ipilimumab Increases Activated T Cells and Enhances Humoral Immunity in Patients With Advanced Melanoma
Published in Journal of immunotherapy (1997) (2012)“…Ipilimumab, a fully human monoclonal antibody, which blocks cytotoxic T-lymphocyte antigen-4, has demonstrated an improvement in overall survival in 2 phase…”
Get full text
Journal Article